What's the INNOVTE network?
INNOVTE, new labellised F-Crin network, aims to develop translational clinical research and European clinical studies on Venous ThromboEmbolism.
Venous ThromboEmbolism, a health issue
Venous ThromboEmbolism (VTE) includes Deep Vein Thrombosis (DVT), Superficial Vein Thrombosis (SVT) and pulmonary embolism. Deep vein thrombosis is the formation of a blood clot within a deep vein predominantly in the legs. Pulmonary Embolism, a potentially life threatening complication, is caused by the detachment of a clot that migrates to the lungs. We estimate about 150 000 new cases of Venous ThromboEmbolism in France.
From GIRC-THROMBOSE to INNOVTE
GIRC THROMBOSE FRANCE was created to develop research in Venous ThromboEmbolism. This network has been funded by INSERM since 2005 and CeNGEPS since 2008. It consists of 12 Clinical Investigation Centres (CIC) including 5 leaders (Brest, Grenoble, Montpellier, Paris HEGP et Saint-Etienne) and 56 Investigation Centers.
For the F-Crin call, 7 biological and imaging teams will join the GIRC THROMBOSE in order to create the new INNOVTE network.